Dexamethasone Phonophoresis Versus Laser Acupuncture on Chronic Rhinosinusitis

Launched by CAIRO UNIVERSITY · Sep 25, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age range between 30 to 50 years.
• • Male and female patients will participate in the study.
• * All patients have chronic rhinosinusitis, who are experiencing 12 weeks or longer of 2 or more of the following signs and symptoms:
• • mucopurulent drainage (anterior, posterior, or both) nasal obstruction (congestion) facial pain-pressure-fullness, or decreased sense of smell
• • • All patients enrolled in the study will have their informed consent.
• Exclusion Criteria:
• • Patients with metal implants (pacemakers, dental implants, or any other implants).
• • Patients with cancer, pregnancy or impaired vascular circulation.
• • Patients who suffer from mental or psychological disorders.
• • Patients with any systemic diseases that may interfere with the objectives of the study.
• • Patients with long-term use of corticosteroids or immunosuppressive agents.
• • Congenital defects on face and nose.
• • Fracture of nose or face.
• • Patients who are contraindicated for corticosteroids use in patient who will receive dexamethasone phonophoresis.
• • Allergic patients.
• • Pervious nasal surgery.
• • Patients with nasal septum deviation.
• • patients who had used antihistamines within 1 week, topical corticosteroids within2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks or any medication that may interfere with the objectives of the study.